These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 21885969)
1. Calcineurin inhibitors in kidney transplantation: friend or foe? Casey MJ; Meier-Kriesche HU Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):610-5. PubMed ID: 21885969 [TBL] [Abstract][Full Text] [Related]
2. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Tönshoff B; Höcker B Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497 [TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Flechner SM; Kobashigawa J; Klintmalm G Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899 [TBL] [Abstract][Full Text] [Related]
4. The safety of calcineurin inhibitors for kidney-transplant patients. Malvezzi P; Rostaing L Expert Opin Drug Saf; 2015 Oct; 14(10):1531-46. PubMed ID: 26329325 [TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitor-free protocols: risks and benefits. Barbari AG; Stephan AG; Masri MA Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):1-23. PubMed ID: 17237886 [TBL] [Abstract][Full Text] [Related]
6. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation. Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219 [TBL] [Abstract][Full Text] [Related]
7. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation. Helal I; Chan L Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737 [TBL] [Abstract][Full Text] [Related]
8. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade. Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546 [TBL] [Abstract][Full Text] [Related]
9. Optimizing the immunosuppressive regimen in heart transplantation. Eisen H; Ross H J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients. Oh CK; Huh KH; Ha J; Kim YH; Kim YL; Kim YS Transplantation; 2015 Jan; 99(1):180-6. PubMed ID: 24983307 [TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant. Boswell A; Evans L; Rigg K; Shehata M Transplant Proc; 2005 Mar; 37(2):884-5. PubMed ID: 15848564 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum. Tredger JM; Brown NW; Dhawan A Drugs; 2008; 68(10):1385-414. PubMed ID: 18578558 [TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation. Kamar N; Del Bello A; Belliere J; Rostaing L Transpl Int; 2015 Aug; 28(8):928-37. PubMed ID: 25557802 [TBL] [Abstract][Full Text] [Related]
19. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience. Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function. Nojima M; Yamada Y; Higuchi Y; Shimatani K; Kanematsu A; Yamamoto S Transplant Proc; 2017; 49(1):41-44. PubMed ID: 28104155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]